Insulin resistance correlates with disease severity in CTEPH, and an indicator may help predict clinical worsening in ...
Tenax Therapeutics said it extended Phase 3 clinical development of PH treatment TNX-103, an oral form of levosimendan.
Columnist Anna Jeter shares memories from high school and the lessons she's learned about advocating for accessibility and ...
Celastrol, a herbal compound in traditional Chinese medicine, may help prevent BPD-PH by reducing inflammation and protecting ...
Inhibiting the AURKB enzyme significantly improves multiple measures of blood flow in rats with pulmonary arterial ...
Adding Winrevair to standard pulmonary arterial hypertension (PAH) treatment is generally safe and effective, a pooled trial ...
When it comes to sharing advice, many people with rare diseases excel at practicing what they preach, says columnist.
Cuts to federal budgets have the rare disease community on edge. Columnist Jen Cueva calls on us to unite for our future.